Cell Impact AB (CI) Stock Statistics & Valuation Metrics

Cell Impact AB has a market cap or net worth of kr99.57M. The enterprise value is kr108.18M.

Cell Impact AB has 3,829,491,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cell Impact AB’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -39.64%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Cell Impact AB had revenue of 37.33M and earned -100.43M in profits. Earnings per share was -0.16.

In the last 12 months, operating cash flow was -61.44M and capital expenditures -22.55M, giving a free cash flow of -83.98M billion.

Cell Impact AB pays an annual dividend of ―, resulting in a dividend yield of ―

Cell Impact AB upcoming earnings date is ―, ―.

Cell Impact AB as a current ratio of 3.03, with Debt / Equity ratio of 14.11%

In the past 12 months, Cell Impact AB has paid 85.00K in taxes.

Cell Impact AB EV to EBITDA ratio is -1.52, with an EV/FCF ratio of -1.34.

Cell Impact AB has kr20.39M in cash and marketable securities with kr30.92M in debt, giving a net cash position of kr10.53M billion.

Gross margin is -164.90%, with operating margin of -265.29%, and net profit margin of -269.08%.

The average price target for Cell Impact AB is ―, which is 11.43% higher than the current price. The consensus rating is ―